Phone: +49 6151 8102-0
Fax: +49 6151 8102-40
Department/ Name Address
Klinische Diagnostik / Dr. Wolfgang Schartl email@example.com
Number of employees 100-499
Sales volume 10-49 Mio US $
Export content max. 50%
Year of foundation 1988
Area of business Diagnostics
Language: German Language: English Company Profile
Comprehensive solution from a single source
The R-Biopharm group is a leading developer of solutions for clinical diagnostics and food and feed analysis. In both sectors the company’s innovative test kits are relied upon for their analytical precision, a high priority when patient and consumer health is at stake.
The german mother company R-Biopharm AG was founded in 1988 as a subsidiary of Röhm GmbH in Darmstadt, Germany. In 1991 it was taken over by the present managing director, Dr. Ralf M. Dreher. Since 1996 R-Biopharm’s quality management systems have been certified to the international standard ISO 9001. In 2003 the company gained ISO 13485 quality management certification. Today R-Biopharm AG has subsidiaries in the UK, USA, Italy, France, Spain, Latin America, Brasil and China and is also represented worldwide by an extensive network of more than 80 distributors.
In clinical diagnostics R-Biopharm possesses many years of sound experience, particularly in the field of infectological stool diagnostics but as well in the field of serological infection diagnostics and allergy diagnostics. 2006 the clinical product portfolio was extended by inovative test systems in the product lines tumor diagnostics and gastroenterology. For most clinical ELISA tests R-Biopharm provides flexible automation solutions that can be adapted to the specific needs of the individual laboratory. RIDASCREEN®, RIDA® and PentoCheck® were world-wide recognized trademarks of R-Biopharm. All distributed tests are validated and CE-marked.
R-Biopharm’s distinctive policy of partner-ship and teamwork is an approach valued by its customers and research partners alike. The company’s key objective is to be a dependable point of contact for customers, providing competent advice on every sector it serves. At R-Biopharm the future looks set to offer further exciting prospects in the fields of clinical diagnostics and food and feed analysis. The foremost challenge is to advance the development of new and versatile fast tests. These will shorten the time it takes to obtain results from a wide range of analytical procedures.